Literature DB >> 9185226

Autopsy findings in the Wolcott-Rallison syndrome.

C M Thornton1, D J Carson, F J Stewart.   

Abstract

Wolcott-Rallison syndrome is a rare autosomal recessive condition characterized by diabetes mellitus arising in early infancy and multiple epiphyseal dysplasia. To date, nine cases have been described in the world literature. We report an affected girl who died at the age of 4 years and on whom a full autopsy was performed. In addition to neonatal diabetes mellitus and epiphyseal dysplasia, this child had mental retardation and recurrent episodes of self-limiting hepatic failure. Autopsy revealed severe pancreatic hypoplasia and markedly abnormal pancreatic histology, while histology of the bone was consistent with epiphyseal dysplasia. There was laryngeal stenosis and pulmonary hypoplasia. The heart was enlarged with mitral value dysplasia and stenosis, left atrial dilatation, left ventricular hypertrophy, and endocardial fibroelastosis. Examination of the central nervous system showed arrhinencephaly and cerebellar cortical dysplasia. The liver showed minor histological abnormalities but no features were present to account for the recurrent hepatic failure. In addition to Wolcott-Rallison syndrome this child had a deletion at 15q11-12 in 65% of her cells.

Entities:  

Mesh:

Year:  1997        PMID: 9185226

Source DB:  PubMed          Journal:  Pediatr Pathol Lab Med        ISSN: 1077-1042


  20 in total

1.  Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility.

Authors:  Mimi A Trinh; Hanoch Kaphzan; Ronald C Wek; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Cell Rep       Date:  2012-05-24       Impact factor: 9.423

2.  Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes.

Authors:  Seiichi Oyadomari; Akio Koizumi; Kiyoshi Takeda; Tomomi Gotoh; Shizuo Akira; Eiichi Araki; Masataka Mori
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.

Authors:  Mariapaola Sidoli; Nicolò Musner; Nicholas Silvestri; Daniela Ungaro; Maurizio D'Antonio; Douglas R Cavener; M Laura Feltri; Lawrence Wrabetz
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

Review 4.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

Review 5.  Wolcott-Rallison syndrome.

Authors:  Cécile Julier; Marc Nicolino
Journal:  Orphanet J Rare Dis       Date:  2010-11-04       Impact factor: 4.123

Review 6.  Translational control by eIF2α kinases in long-lasting synaptic plasticity and long-term memory.

Authors:  Mimi A Trinh; Eric Klann
Journal:  Neurobiol Learn Mem       Date:  2013-05-22       Impact factor: 2.877

7.  Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response.

Authors:  Hao-Yuan Jiang; Sheree A Wek; Barbara C McGrath; Dan Lu; Tsonwin Hai; Heather P Harding; Xiaozhong Wang; David Ron; Douglas R Cavener; Ronald C Wek
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses.

Authors:  Hao-Yuan Jiang; Sheree A Wek; Barbara C McGrath; Donalyn Scheuner; Randal J Kaufman; Douglas R Cavener; Ronald C Wek
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 9.  The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.

Authors:  Donalyn Scheuner; Randal J Kaufman
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 10.  Neonatal diabetes mellitus.

Authors:  Lydia Aguilar-Bryan; Joseph Bryan
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.